NCT03865953View on ClinicalTrials.gov

Oral LAT8881 in Neuropathic Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

April 9, 2019

Primary Completion Date

April 19, 2020

Study Completion Date

May 3, 2020

Conditions
Neuropathic PainDiabetic Peripheral Neuropathy (DPN)Post Herpetic Neuralgia (PHN)
Interventions
DRUG

LAT8881

LAT8881 oral capsule

DRUG

Placebo

Placebo oral capsule

Trial Locations (6)

2148

Paratus Clinical Research Blacktown, Sydney

2259

Paratus Clinical Research Kanwal, Kanwal

3124

Emeritus Research Services, Melbourne

4075

AusTrials, Brisbane

BS8 1TD

University of Bristol, Bristol

G121 3UW

Queen Elizabeth University Hospital, Glasgow

Sponsors
All Listed Sponsors
lead

Lateral Pharma Pty Ltd

INDUSTRY